Appendix 4E and Financial Report 30 June 2025
Filed with ASX · · 95 pages · English
Summary by 6ix AI
The report highlights a notable increase in total revenue and profit attributable to members, alongside a fully franked final dividend declaration. The company emphasizes operational improvements and strategic initiatives that contributed to its financial performance during the period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Australian Clinical Labs Ltd on 6ix
In the deck
Earlier from Australian Clinical Labs
- FY25 Results Announcement
- FY25 Results Presentation
- Response to ASX Aware Letter
- Appendix 4D and 1H25 financial statements
- 1H25 financial results investor presentation
Later from Australian Clinical Labs
- AIC proceedings - update
- On Market Share Buy Back
- ACL 1H26 financial results investor presentation
- Appendix 4D and 1H26 financial reports
- CEO contract update
Follow Australian Clinical Labs into a list and get an email when it puts out news.
Follow Australian Clinical Labs